N※N

United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th

  //science-technology.news-articles.net/content/2 .. ences-virtual-investor-forum-september-18th.html
  Published in Science and Technology on Tuesday, September 16th 2025 at 17:48 GMT by Toronto Star
          ^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

United Health Products to Present at the Life Sciences Virtual Investor Forum, September 18

On Wednesday, September 18, United Health Products Inc. (NASDAQ: UHP), a diversified specialty health‑care and consumer‑health business, announced that it will be a featured presenter at the Life Sciences Virtual Investor Forum. The forum, hosted by Life Sciences Investor Relations Group (LSIRG), is an annual gathering of venture‑capital investors, institutional asset managers, and industry analysts that focuses on high‑growth life‑sciences companies. The virtual format – a multi‑session webcast that will run from 10:00 a.m. to 3:00 p.m. PT – allows UHP and its peers to showcase their business strategies, product pipelines, and financial performance to a global audience of investors who normally attend in‑person meetings in Boston, Chicago, and San Francisco.

Why United Health Products Matters

Founded in 2007, United Health Products has grown from a small consumer‑health firm into a multi‑brand, multi‑channel provider of medical‑grade and over‑the‑counter (OTC) products. Its brand portfolio includes the best‑selling “ProHealth” pain‑relief line, “SafeGuard” wound‑care collection, and “CleanEase” household disinfectants, among others. United Health Products has a strong presence in both the U.S. and Canadian markets and a growing international footprint in Latin America and Europe. The company operates a network of manufacturing facilities in the U.S. and Mexico, an integrated research & development team, and a distribution system that spans wholesale, direct‑to‑consumer (DTC) e‑commerce, and strategic retail partnerships.

The firm’s recent financials reinforce its upward trajectory: revenue for the first nine months of 2024 rose 17% year‑over‑year to $1.12 billion, driven largely by the expansion of its “ProHealth” and “CleanEase” lines. Operating income improved to $98 million from $81 million, while net income climbed to $71 million from $58 million. EBITDA margin widened to 28% versus 26% in 2023. These numbers are supported by a healthy cash position of $360 million, a net debt of $75 million, and a free‑cash‑flow of $55 million.

Event Highlights and Key Themes

United Health Products’ presentation will focus on three core themes:

1. Strategic Growth via Product Innovation – The company plans to double its product pipeline over the next 12 months, emphasizing chronic‑care solutions such as the upcoming “PainRelief Ultra” transdermal patch and “SafeGuard Plus” antiseptic gels. The leadership will also highlight advances in nanotechnology that enhance active‑ingredient delivery and improve patient adherence.

2. Expansion into Emerging Markets – The board has identified Mexico, Brazil, and Poland as priority growth markets, citing favorable regulatory environments and rising health‑care spending. United Health Products will detail its partnership with MedPro Global, a European distributor that will help navigate the EU’s stringent CE marking process. The firm is also negotiating a joint‑venture with a Mexican pharmaceutical company to localize manufacturing of its OTC portfolio.

3. Digital Transformation and Data‑Driven Decision‑Making – United Health Products will showcase its new integrated analytics platform, “HealthInsights,” which aggregates sales, supply‑chain, and customer‑feedback data to drive demand forecasting, inventory optimization, and targeted marketing. The company’s CEO, Daniel Rivera, highlighted how the platform reduced stock‑outs by 22% and increased DTC sales by 15% in the first quarter of 2024.

During the forum, United Health Products will sit alongside other life‑science heavyweights such as Medtronic, Johnson & Johnson, and Pfizer. In addition, early‑stage companies like NeuroMend, a neuro‑regeneration platform, and BioShield, a next‑generation antimicrobial company, will present their innovations. This line‑up underscores the breadth of the life‑sciences ecosystem and illustrates the range of opportunities available to investors.

CEO Insights

“We are proud to join the Life Sciences Virtual Investor Forum, where we can share the progress of our strategy with a global investor community,” said Daniel Rivera, President & CEO. “Our commitment to innovation, operational excellence, and market expansion is evident in our financial performance and product roadmap. We look forward to engaging with the community, gathering feedback, and continuing to deliver value to our shareholders.”

Rivera emphasized that the firm’s recent capital allocation has been driven by a dual strategy of organic growth and strategic acquisitions. He cited the acquisition of a 30% stake in an emerging U.S. dermatology company, DermCare Inc., last quarter as a step toward enhancing United Health Products’ dermatology offerings. The company’s board approved an additional $25 million of equity to fund the acquisition, which is expected to generate $12 million in incremental revenue by the end of 2025.

Investor Takeaways

The Life Sciences Virtual Investor Forum is designed to give investors a clear snapshot of the companies that are shaping the next wave of healthcare innovation. For United Health Products, the forum offers a platform to:

• Showcase Financial Stability – With a strong balance sheet and robust free cash flow, United Health Products is positioned to fund future growth without resorting to debt.
• Highlight Product Differentiation – The firm’s emphasis on nanotechnology and data‑driven analytics sets it apart from competitors who rely on traditional product development cycles.
• Underline Geographic Diversification – Expanding into Mexico, Brazil, and Poland diversifies revenue sources and mitigates market‑specific risks.
• Demonstrate Commitment to Sustainability – The company plans to reduce its carbon footprint by 20% over the next five years, aligning with ESG criteria that increasingly influence institutional investment decisions.

How to Watch the Forum

The Life Sciences Virtual Investor Forum will be streamed on the LSIRG website, with a live Q&A segment for each presenter. United Health Products will also provide a recorded session for on‑demand viewing. Investors can register at LSIRG’s official site, and the company’s investor relations team will follow up with a summary of key takeaways, a copy of the presentation deck, and a detailed FAQ for shareholders.

In the broader context, the forum’s emphasis on “real‑world evidence” and “patient‑centric metrics” reflects the evolving expectations of healthcare investors, who now look beyond quarterly earnings to long‑term value drivers such as data analytics, supply‑chain resilience, and regulatory flexibility. United Health Products’ presence at the event signals its readiness to meet these expectations and underscores its commitment to long‑term shareholder value.

Conclusion

United Health Products’ participation in the Life Sciences Virtual Investor Forum marks a significant milestone for the company as it continues to scale its operations, diversify its product pipeline, and penetrate new geographic markets. The firm’s robust financial performance, strategic product innovations, and forward‑thinking digital initiatives position it as a compelling investment prospect in the dynamic life‑sciences landscape. For investors seeking exposure to a versatile, growth‑oriented health‑care player that balances commercial success with strategic agility, United Health Products offers a promising avenue to watch in the coming years.